Moderna, Inc.MRNA

Market cap

$12.7B

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	658	248	2,636	6,860	3,217	2,928	1,929
Marketable securities, current	863	867	1,984	3,879	6,697	5,697	5,098
Total cash & short-term investments	1,521	1,115	4,620	10,739	9,914	8,625	7,027
Accounts receivable, net	12	5	1,391	3,175	1,385	892	358
Inventories	-	-	47	1,441	949	202	117
Total current assets	1,563	1,129	6,298	16,071	13,431	10,325	8,099
Property, plant and equipment, net	212	-	-	-	-	-	-
Marketable securities, non-current	173	160	639	6,843	8,318	4,677	2,494
Total non-current assets	399	461	1,039	8,598	12,427	8,101	6,043
Total assets	1,962	1,589	7,337	24,669	25,858	18,426	14,142
Accounts payable	31	7	18	302	487	520	405
Total current liabilities	223	143	4,389	9,128	4,923	3,015	2,206
Total non-current liabilities	209	271	387	1,396	1,812	1,557	1,035
Total liabilities	432	415	4,775	10,524	6,735	4,572	3,241
Common stock and paid-in capital	2,538	2,669	4,802	4,211	1,173	371	866
Retained earnings	-1,000	-1,496	-2,240	9,958	18,320	13,606	10,045
Stockholders' equity	1,530	1,175	2,561	14,145	19,123	13,854	10,901
Working capital	-	-